ALVOTECH SA Share Price Today: Live Updates & Key Insights
ALVOTECH SA share price today is $3.535, up -1.4%. The stock opened at $3.53 against the previous close of $3.58, with an intraday high of $3.615 and low of $3.44.
ALVOTECH SA Share Price Chart
ALVOTECH SA
ALVOTECH SA Share Price Performance
ALVOTECH SA Institutional Holdings
ALVOTECH SA Market Status
ALVOTECH SA Fundamentals
Market Cap 1099.95 M
PB Ratio 0.0
PE Ratio 15.3478
Enterprise Value 2340.82 M
Total Assets 1221.40 M
Volume 1261633
ALVOTECH SA Company Financials
About ALVOTECH SA & investment objective
Company Information Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.
Organisation Drug Manufacturers - Specialty & Generic
Employees 1012
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Vilhelm Robert Wessman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ALVOTECH SA FAQs
What is the share price of ALVOTECH SA today?
The current share price of ALVOTECH SA is $3.535.
Can I buy ALVOTECH SA shares in India?
Yes, Indian investors can buy ALVOTECH SA shares by opening an international trading and demat account with Motilal Oswal.
How to buy ALVOTECH SA shares in India?
You can easily invest in ALVOTECH SA shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ALVOTECH SA shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ALVOTECH SA.
Can I buy fractional shares of ALVOTECH SA?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ALVOTECH SA?
ALVOTECH SA has a market cap of $1099.95 M.
In which sector does ALVOTECH SA belong?
ALVOTECH SA operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in ALVOTECH SA stocks?
To invest, you typically need:
What is the PE and PB ratio of ALVOTECH SA?
The PE ratio of ALVOTECH SA is 15.35 and the PB ratio is N/A.